Radoslav Goldman

Summary

Affiliation: Georgetown University
Country: USA

Publications

  1. ncbi Detection of hepatocellular carcinoma using glycomic analysis
    Radoslav Goldman
    Department of Oncology, Georgetown University, Washington, District of Columbia 20057 1469, USA
    Clin Cancer Res 15:1808-13. 2009
  2. ncbi MS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration
    Juraj Lenco
    Georgetown University, Department of Oncology, Lombardi Comprehensive Cancer Center, 3970 Reservoir Rd NW, Washington, DC 20057, USA
    Proteome Sci 10:7. 2012
  3. ncbi A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins
    Peter D Burbelo
    Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA
    BMC Biotechnol 5:22. 2005
  4. ncbi Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum
    Radoslav Goldman
    Georgetown University, Lombardi Comprehensive Cancer Center, 3970 Reservoir Road Northwest, Washington, DC 20057, USA
    Carcinogenesis 28:2149-53. 2007
  5. ncbi Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma
    Habtom W Ressom
    Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA
    J Proteome Res 7:603-10. 2008
  6. ncbi Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry
    Rency S Varghese
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
    Conf Proc IEEE Eng Med Biol Soc 2008:3791-4. 2008
  7. ncbi Ant colony optimization for biomarker identification from MALDI-TOF mass spectra
    Habtom W Ressom
    Lombardi Comprehensive Cancer Center, Georgetown Univ, Washington, DC, USA
    Conf Proc IEEE Eng Med Biol Soc 1:4560-3. 2006
  8. ncbi Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma
    Yanming An
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road NW, Washington, DC 20057, USA
    Dis Markers 29:11-20. 2010
  9. ncbi Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data
    Zhiqun Tang
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA
    J Proteome Res 9:104-12. 2010
  10. ncbi Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma
    Eduard Orvisky
    Georgetown University, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20057-1469, USA
    Proteomics 6:2895-902. 2006

Research Grants

  1. Glycans in Hepatocellular Carcinoma
    Radoslav Goldman; Fiscal Year: 2009
  2. Effects of smoking on ERb and AHR pathway in human lung
    Radoslav Goldman; Fiscal Year: 2004
  3. Proteomic Analysis of Serum in Liver Cancer
    Radoslav Goldman; Fiscal Year: 2007
  4. Optimization of enrichment for MALDI TOF/TOF identification of cancer biomarkers
    Radoslav Goldman; Fiscal Year: 2007
  5. Proteomic Analysis of Serum in Liver Cancer
    Radoslav Goldman; Fiscal Year: 2009
  6. Proteomic Analysis of Serum in Liver Cancer
    Radoslav Goldman; Fiscal Year: 2010
  7. Glycans in Hepatocellular Carcinoma
    Radoslav Goldman; Fiscal Year: 2010

Collaborators

Detail Information

Publications23

  1. ncbi Detection of hepatocellular carcinoma using glycomic analysis
    Radoslav Goldman
    Department of Oncology, Georgetown University, Washington, District of Columbia 20057 1469, USA
    Clin Cancer Res 15:1808-13. 2009
    ..The objective of our study was to quantitatively assess N-glycans originating from serum glycoproteins as alternative markers for the detection of HCC...
  2. ncbi MS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration
    Juraj Lenco
    Georgetown University, Department of Oncology, Lombardi Comprehensive Cancer Center, 3970 Reservoir Rd NW, Washington, DC 20057, USA
    Proteome Sci 10:7. 2012
    ..The added value of the workflow is demonstrated in the development of a triplex LC-MRM MS assay used for quantification of peptides potentially associated with the progression of liver disease to hepatocellular carcinoma...
  3. ncbi A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins
    Peter D Burbelo
    Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA
    BMC Biotechnol 5:22. 2005
    ....
  4. ncbi Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum
    Radoslav Goldman
    Georgetown University, Lombardi Comprehensive Cancer Center, 3970 Reservoir Road Northwest, Washington, DC 20057, USA
    Carcinogenesis 28:2149-53. 2007
    ..Further evaluation of these marker candidates for the diagnosis of HCC is needed...
  5. ncbi Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma
    Habtom W Ressom
    Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA
    J Proteome Res 7:603-10. 2008
    ..Further evaluation is needed to examine the potential clinical utility of the candidate peptide and glycan markers identified in this study...
  6. ncbi Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry
    Rency S Varghese
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
    Conf Proc IEEE Eng Med Biol Soc 2008:3791-4. 2008
    ..The performance of these markers is evaluated in terms of their ability to distinguish HCC cases from patients with CLD in a blinded validation set...
  7. ncbi Ant colony optimization for biomarker identification from MALDI-TOF mass spectra
    Habtom W Ressom
    Lombardi Comprehensive Cancer Center, Georgetown Univ, Washington, DC, USA
    Conf Proc IEEE Eng Med Biol Soc 1:4560-3. 2006
    ..The results indicate that the MALDI-TOF technology could provide the means to discover novel biomarkers for HCC...
  8. ncbi Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma
    Yanming An
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road NW, Washington, DC 20057, USA
    Dis Markers 29:11-20. 2010
    ..These peptides could potentially serve as markers of HCC following additional validation studies; however, association of similar peptides with other diseases and cancers dictates a very cautious approach...
  9. ncbi Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data
    Zhiqun Tang
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA
    J Proteome Res 9:104-12. 2010
    ..The method of this study is significant in deriving consistent, accurate, and biological significant glycan marker candidates for hepatocellular carcinoma diagnosis...
  10. ncbi Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma
    Eduard Orvisky
    Georgetown University, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20057-1469, USA
    Proteomics 6:2895-902. 2006
    ..This study shows that enrichment of the low molecular weight fraction of serum facilitates an efficient discovery of peptides that could serve as biomarkers for detection of HCC as well as other diseases...
  11. ncbi Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search
    Petr Pompach
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road NW, Washington, DC 20057 1465, United States
    J Proteome Res 11:1728-40. 2012
    ..The optimized workflow, coupled with GlycoPeptideSearch, is expected to make high-throughput semiautomated glycopeptide identification feasible for a wide range of users...
  12. ncbi Acrolein-derived DNA adduct formation in human colon cancer cells: its role in apoptosis induction by docosahexaenoic acid
    Jishen Pan
    Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road NW, Washington, DC 20057, USA
    Chem Res Toxicol 22:798-806. 2009
    ..Taken together, these results demonstrate the parallel relationships between Acr-dG level and apoptosis in HT-29 cells, suggesting that the formation of Acr-dG in cellular DNA may contribute to apoptosis induced by DHA...
  13. ncbi Analysis of mass spectral serum profiles for biomarker selection
    Habtom W Ressom
    Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
    Bioinformatics 21:4039-45. 2005
    ..We present low-level methods for the processing of mass spectral data and a machine learning method that combines support vector machines, with particle swarm optimization for biomarker selection...
  14. ncbi Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis
    Habtom W Ressom
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
    Anal Chim Acta 743:90-100. 2012
    ..Our work shows that metabolomic profiling is a promising tool to identify candidate metabolic biomarkers for early detection of HCC cases in high risk population of cirrhotic patients...
  15. ncbi Proteome-wide analysis of single-nucleotide variations in the N-glycosylation sequon of human genes
    Raja Mazumder
    Department of Biochemistry and Molecular Biology, George Washington University Medical Center, Washington, DC, USA
    PLoS ONE 7:e36212. 2012
    ....
  16. ncbi Quantification of DNA repair capacity in whole blood of patients with head and neck cancer and healthy donors by comet assay
    Daniel T Saha
    Georgetown University, Department of Oncology, Washington, DC 20057, USA
    Mutat Res 650:55-62. 2008
    ..Additional method optimization would be helpful to improve the assay for a large population screening...
  17. ncbi Site-specific Glycoforms of Haptoglobin in Liver Cirrhosis and Hepatocellular Carcinoma
    Petr Pompach
    Department of Oncology, Georgetown University, Washington, D C 20057
    Mol Cell Proteomics 12:1281-93. 2013
    ..The presence of multiply fucosylated Lewis Y glycoforms of haptoglobin in the disease context could have important functional implications...
  18. ncbi The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells
    Lixin Mi
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia 20057, USA
    Cancer Res 67:6409-16. 2007
    ..Because PEITC is a stronger inducer of apoptosis than SFN, these results indicate that direct covalent binding to cellular proteins is an important early event in the induction of apoptosis by the ITCs...
  19. ncbi Urinary estrogen metabolites and prostate cancer risk: a pilot study
    Ourania Kosti
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia 20057, USA
    Prostate 71:507-16. 2011
    ..The aim of this pilot study was to evaluate urinary estrogen metabolites as a biomarker of prostate cancer risk...
  20. ncbi Structure-based Comparative Analysis and Prediction of N-linked Glycosylation Sites in Evolutionarily Distant Eukaryotes
    Phuc Vinh Nguyen Lam
    Life Sciences Department, Paris Diderot University, Paris 75013, France Department of Biochemistry and Molecular Biology, George Washington University Medical Center, Washington, DC 20037, USA
    Genomics Proteomics Bioinformatics 11:96-104. 2013
    ..The tool, Structure Feature Analysis Tool (SFAT), is freely available to the public at http://hive.biochemistry.gwu.edu/tools/sfat...
  21. ncbi Decreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugs
    Neda Ahmadi
    Department of Otolaryngology Head and Neck Surgery, Georgetown University Hospital, Washington, DC 20007, USA
    Int J Otolaryngol 2010:424161. 2010
    ..This study provides evidence for a significant reduction in the risk of developing HNSCC in users of NSAIDs, and specifically aspirin users...
  22. ncbi Food mutagens
    Radoslav Goldman
    Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, USA
    J Nutr 133:965S-973S. 2003
    ..This article reviews the role of food mutagens in mutagenesis and carcinogenesis and how their effects are modified by heritable traits and discusses how to identify and evaluate the effects of food mutagens...
  23. ncbi A sensitive immunofluorescence assay for detection of p53 protein in the sputum
    Zumei Feng
    Department of Oncology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, USA
    Methods Mol Med 75:389-95. 2003

Research Grants8

  1. Glycans in Hepatocellular Carcinoma
    Radoslav Goldman; Fiscal Year: 2009
    ..The identified sugars could be used to screen high risk populations for early signs of liver cancer; to design and test new chemoprevention strategies; and to follow disease progression after treatment. ..
  2. Effects of smoking on ERb and AHR pathway in human lung
    Radoslav Goldman; Fiscal Year: 2004
    ..The grant would provide critical support for this pilot study, whose results will lead to refined hypotheses testable in future research. ..
  3. Proteomic Analysis of Serum in Liver Cancer
    Radoslav Goldman; Fiscal Year: 2007
    ..Identification of the P/P is expected to generate new hypotheses for targeted disease management. ..
  4. Optimization of enrichment for MALDI TOF/TOF identification of cancer biomarkers
    Radoslav Goldman; Fiscal Year: 2007
    ..Identification of the P/P is expected to generate new hypotheses for targeted disease management. ..
  5. Proteomic Analysis of Serum in Liver Cancer
    Radoslav Goldman; Fiscal Year: 2009
    ..Identification of the P/P is expected to generate new hypotheses for targeted disease management. ..
  6. Proteomic Analysis of Serum in Liver Cancer
    Radoslav Goldman; Fiscal Year: 2010
    ..Identification of the P/P is expected to generate new hypotheses for targeted disease management. ..
  7. Glycans in Hepatocellular Carcinoma
    Radoslav Goldman; Fiscal Year: 2010
    ..The identified sugars could be used to screen high risk populations for early signs of liver cancer;to design and test new chemoprevention strategies;and to follow disease progression after treatment. ..